Drugs
-
Topiramate (marketed as Topamax) Information
Topiramate is an anticonvulsant medication approved for use alone or with other medications to treat patients with epilepsy who have certain types of seizures.
To report any serious adverse events associated with the use of these drugs, please contact the FDA MedWatch program using the contact information at the bottom of this page.
-
Related Information
FDA Drug Safety Podcast for Healthcare Professionals: Risk of oral clefts in children born to mothers taking Topamax (topiramate)
3/4/2011FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate)
3/4/2011Questions and Answers: Risk of oral clefts (cleft lip and/or palate) in infants born to mothers taking Topamax (Topiramate)
3/4/2011FDA: Risk of oral birth defects in children born to mothers taking topiramate
Press Release - 3/4/2011- Podcast for Healthcare Professionals: Risk of oral clefts in children born to mothers taking Topamax (topiramate)
3/4/2011 Suicidal Behavior and Ideation and Antiepileptic Drugs
5/5/2009
-
-
Labeling and Regulatory History from Drugs@FDA
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-
